The Centers for Medicare and Medicaid Services is considering endorsing a different drug classification standard for private insurance plans serving the individual and small group markets that could encourage broader coverage of weight loss drugs.
The change could be timely for a new generation of obesity drugs currently fighting to overcome obstacles to coverage, including...